Geist will be responsible for developing PerkinElmer's strategic partnerships and acquisition opportunities
PerkinElmer has announced the appointment of Aaron Geist as vice president, business development.
Geist joins PerkinElmer from Robert W Baird where he served as director and senior research analyst.
In this role, he was responsible for generating investor research on 22 life sciences, medical diagnostics and medical device companies, and was chosen as a top analyst by both the Wall Street Journal and Forbes/StarMine in 2004.
He previously worked in medical research with a specialisation in infectious diseases.
Geist holds a PhD in microbiology and molecular virology from Thomas Jefferson University in Philadelphia, Pennsylvania, and bachelor of science degrees in genetics and biology from the University of Western Ontario in Canada.
"Aaron brings exceptional domain knowledge, market understanding and business acumen to his new role," said Robert Friel, vice chairman of PerkinElmer.
"We look forward to his leadership in developing and growing the PerkinElmer business portfolio, particularly in the areas of molecular medicine, genetic screening and medical imaging."
